ROLE OF MULTIDRUG TREATMENT IN MYCOBACTERIUM TUBERCULOSIS: AN OVERVIEW

Tuberculosis is a bacterial infection, affecting the lungs. Tuberculosis has been a leading cause of death since many years. With the evolution of science and technology, many related drugs have been discovered. They have a prescribed schedule and the dosage relies on symptomatic treatment. This is because with time and doses, the microorganism evolves and adapts new methods to resist antibiotics. This causes multi-drug resistance in organisms, leading to an increase in the potential of the bacterial colonies. This poses a threat to the person and so on. This paper highlights the development of anti-tuberculin drugs, their role in treatment and their mechanisms of resistance.